TrialPloS one2018

Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.

John J Bissler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.